Zyloprim
NDC Package 70199-032-90

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Zyloprim is allopurinol is used to treat gout and certain types of kidney stones. Marketed by Casper Pharma Llc, this product is identified by NDC 70199-032 and is authorized under FDA application NDA016084.

Identification & Billing

NDC Package Code
70199-032-90
Package Description
90 TABLET in 1 BOTTLE
Product Code
70199-032
11-Digit Billing Format
70199003290

Clinical Specifications

Proprietary Name
Zyloprim
Dosage Form
-
Usage Information
Allopurinol is used to treat gout and certain types of kidney stones. It is also used to prevent increased uric acid levels in patients receiving cancer chemotherapy. These patients can have increased uric acid levels due to release of uric acid from the dying cancer cells. Allopurinol works by reducing the amount of uric acid made by the body. Increased uric acid levels can cause gout and kidney problems.

Regulatory & Marketing

Labeler Name
Casper Pharma Llc
FDA Application #
NDA016084
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
09-21-2023
End Marketing Date
09-22-2023
Listing Expiration
09-22-2023
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (70199-032). Click a package code to view its specific billing and regulatory data.

70199-032-01
100 TABLET in 1 BOTTLE
70199-032-05
500 TABLET in 1 BOTTLE
70199-032-99
1000 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70199-032-90 identifies a specific commercial package of 90 tablet in 1 bottle of Zyloprim, labeled by Casper Pharma Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Casper Pharma Llc on September 21, 2023. The current certification is valid through September 22, 2023.

What are the primary indications for this medication?

Allopurinol is used to treat gout and certain types of kidney stones. It is also used to prevent increased uric acid levels in patients receiving cancer chemotherapy. These patients can have increased uric acid levels due to release of uric acid from the dying cancer cells. Allopurinol works by reducing the amount of uric acid made by the body. Increased uric acid levels can cause gout and kidney problems.

How is this Casper Pharma Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70199003290. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70199-032-90
11-Digit CMS (5-4-2)
70199-0032-90

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.